Catalyst Wire Dossier Catalyst Wire Dossier

Riboflavin-assisted corneal cross-linking

riboflavin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Riboflavin-assisted corneal cross-linking, covering 2012-12-06 to 2012-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Corneal Sensitivity Cross-linking Keratoconus [Phase 2, Phase 3]

See pricing